Most efforts to fight cancer these days is either through chemicals such as those used in chemotherapy or via genetic engineering. In Japan, researchers went with the latter and used chickens as the tool. The scientists basically engineered poultry to lay eggs that will then be capable of fighting cancer as well as other types of diseases.
The new revolutionary method was performed by researchers at the National Institute of Advanced Industrial Science and Technology (AIST), which is located in the Osaka prefecture, The Japan News reports. Their project resulted in a hen laying eggs, which then contain pharmaceutical agents designed to fight certain illnesses such as cancer and hepatitis.
The researchers are planning on partnering with a research company to sell the drug, which might cut the costs of cancer drugs by as much as half the current price. It doesn’t stop there, either. The researchers are hoping that with this new method, the price of curing cancer will be reduced to a mere 10 percent of what it costs now. At least, this is what professor Hironobu Hojo of Osaka University said.
“This is a result that we hope leads to the development of cheap drugs,” Hojo said to The Japan News. “In the future, it will be necessary to closely examine the characteristics of the agents contained in the eggs and determine their safety as pharmaceutical products.”
The key to the drug lies in a type of protein, which is apparently effective at treating a particularly deadly kind of skin cancer, Futurism reports. This protein was then inserted into the eggs during the fertilization process. Eventually, the latest generation of eggs finally inherited the protein after several rounds of cross-breeding.
In essence, the researchers conducted artificial selection, which is something that gene-editing tools like CRISPR have made infinitely easier. This is just one example of how the future of medicine will be like.


Meta AI Push Could Add $26 Billion in Revenue by 2027, Wolfe Research Says
SpaceX IPO Could Become Largest in History with $1.8 Trillion Valuation Target
Snowflake Stock Soars 30% After Q1 Earnings Beat and Major AWS AI Partnership
Samsung Workers Approve Wage Deal, Avoiding Major Strike and Boosting Chip Supply Confidence
Macquarie Names Five Taiwan AI Stocks Set to Benefit From Data Center Growth in 2026
Salesforce Q1 FY2027 Earnings Beat Expectations Despite Soft Q2 Revenue Outlook
Autodesk Beats Q1 Estimates, Acquires MaintainX for $3.6 Billion
Mega IPOs Like SpaceX and OpenAI Could Reshape S&P 500 and Nasdaq 100 Portfolios in 2026
SpaceX Delays Starship V3 Launch Ahead of Potential Record IPO
Huawei Chip Breakthrough Sparks Rally in Chinese Semiconductor Stocks
Samsung to Invest $1.5 Billion in Vietnam Semiconductor Testing Plant by 2027
Synopsys Q2 FY2026 Earnings Beat Driven by AI and Semiconductor Demand
US Quantum Stocks Surge After $2 Billion Government Investment
Blue Origin New Glenn Rocket Explodes During Launch Pad Test, Delaying Space Ambitions
Morgan Stanley Names Top AI Security and Data Center Stocks for 2026
EU Antitrust Probe Could Lead to Massive Google Fine Under DMA Rules 



